Redefining drug-induced tremor: a mechanism-based framework for clinical and etiological assessment
- 1Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine
Abstract
Drug-induced tremor (DIT) encompasses clinically diverse syndromes with different mechanisms, clinical courses, and management needs. This Perspective proposes a mechanism-based approach to guide evaluation and management by integrating tremor phenotype, drug pharmacology, associated neurological findings, and clinical course. The initial assessment considers peripheral adrenergic amplification, dopamine receptor blockade or depletion, and systemic or neurotoxic effects, while allowing drug-specific assessment when mechanisms are less clearly understood, as with valproate and serotonergic antidepressants. These considerations guide treatment adjustment and targeted investigation. Associated cerebellar, neuropathic, cognitive, or systemic findings guide evaluation for neurotoxicity and metabolic abnormalities. When tremor is accompanied by parkinsonian features, clinical follow-up assesses recovery, persistence, or progression. Dopamine transporter (DAT) imaging is considered when uncertainty about coexisting nigrostriatal degeneration would affect management. Assessment also considers tardive tremor, taking into account its clinical features and the timing of symptoms in relation to prolonged drug exposure and withdrawal. By connecting these assessments to investigation, treatment, follow-up, and counseling, the proposed framework complements the Movement Disorder Society tremor classification and provides a practical approach to the heterogeneity of DIT. Prospective validation is needed to determine its clinical utility.
Related
- Epidemiological, Clinical, and Etiological Profile of Iron Deficiency Anemia in Adults in Southern Morocco: A Five-Year Retrospective Study
- Hybrid Explainable Deep Ensemble Framework with self-attention mechanism for early prediction of depression severity using PHQ-9 clinical and behavioral data
- Redefining success in assisted reproductive technologies: the Embryo-Maternal-Offspring Continuum Framework
- From past to present and toward the future: a mechanism-informed clinical framework for COVID-19-associated headache and post-viral pain
- Quality of Movement Assessment after ACL Reconstruction in Youth: A Clinical Framework to Guide Rehabilitation and Return-to-Sport Decision-Making
BibTeX
@article{shin2026redefining,
title = {{Redefining drug-induced tremor: a mechanism-based framework for clinical and etiological assessment}},
author = {Hae-Won Shin},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1921752},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1921752/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Redefining drug-induced tremor: a mechanism-based framework for clinical and etiological assessment
AU - Hae-Won Shin
PY - 2026
DA - 2026/10/28
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1921752
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1921752/full
AB - Drug-induced tremor (DIT) encompasses clinically diverse syndromes with different mechanisms, clinical courses, and management needs. This Perspective proposes a mechanism-based approach to guide evaluation and management by integrating tremor phenotype, drug pharmacology, associated neurological findings, and clinical course. The initial assessment considers peripheral adrenergic amplification, dopamine receptor blockade or depletion, and systemic or neurotoxic effects, while allowing drug-specific assessment when mechanisms are less clearly understood, as with valproate and serotonergic antidepressants. These considerations guide treatment adjustment and targeted investigation. Associated cerebellar, neuropathic, cognitive, or systemic findings guide evaluation for neurotoxicity and metabolic abnormalities. When tremor is accompanied by parkinsonian features, clinical follow-up assesses recovery, persistence, or progression. Dopamine transporter (DAT) imaging is considered when uncertainty about coexisting nigrostriatal degeneration would affect management. Assessment also considers tardive tremor, taking into account its clinical features and the timing of symptoms in relation to prolonged drug exposure and withdrawal. By connecting these assessments to investigation, treatment, follow-up, and counseling, the proposed framework complements the Movement Disorder Society tremor classification and provides a practical approach to the heterogeneity of DIT. Prospective validation is needed to determine its clinical utility.
SN - 1664-2295
ER -